Insmed terminates $500M equity distribution agreement with Leerink Partners

INSMED Inc

Insmed terminated its Sales Agreement with Leerink Partners LLC, effective November 18, 2024.
The agreement had allowed for up to $500 million in common stock sales; no shares were sold since September 30, 2024.
The company incurred no termination penalties as a result of the agreement's termination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.